FGF5 has been implicated in GWAS of hypertension (Ehret et al. 2011), and other fibroblast growth factors are increasingly recognised as contributors to blood pressure regulation through renal mechanisms (Tomaszewski et al. 2015). Here, FGF5 is linked to hypertensive disorder.